ACCRELIST LTD (QZG) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of ACCRELIST LTD stock S$0.03, price S$0.06, that is 49.9% below the price, quality 53 out of 100. Rating: strongly overvalued. Calculated from audited financials with 6 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
ACCRELIST LTD
QZG · SGFar too expensive (fair value 50% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.
How to read this chart
60‑month range 0.0290 SGD – 0.2050 SGD · the 0.0580 SGD price screens above the 0.0290 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.
Every Wednesday you see whether ACCRELIST is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Accrelist Ltd., an investment holding company, engages in the medical aesthetics business in Singapore, Malaysia, and Indonesia. It operates through three segments: Mechanical Business Unit (MBU), Aesthetic Medical Services (AMS), and Others segment.
Show moreShow less
The MBU segment offers mould design and fabrication services for consumer electronics, household appliances, automotive, and computer peripherals, as well as precision plastic injection moulding services for customers' finished products.
Its AMS segment offers aesthetic services and solutions, including cosmetic dermatology and skin laser services.
The company is also involved in the operation of aesthetic medical clinics; retail sale of pharmaceutical and medical goods; and development and distribution of original design manufacturer (ODM) clinical skincare products and other non-ODM products.
The company was formerly known as WE Holdings Ltd. and changed its name to Accrelist Ltd. in November 2016. Accrelist Ltd. was founded in 1986 and is headquartered in Singapore.
Stock analysis
ACCRELIST LTD (QZG) currently trades at 0.0580 SGD, while our model-based Fair Value estimate is 0.0290 SGD, 50% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 0.0200 SGD per share, and 1 of the 6 models we run sit above the 0.0580 SGD price.
Bear case: the DCF Models group reads lowest at 0.0150 SGD, and 5 of the 6 models stay below the price. Data coverage for this calculation is low.
Quality & growth
The Quality Score stands at 53/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
ACCRELIST LTD reported revenue of 15.6M SGD in FY2026 versus 241M SGD in FY2022, a compound −49.5%/yr. Reported net income was −264K SGD in FY2026.
Key figures
Market cap 18.6M SGD (≈ $14.5M) Micro · P/S ratio 1.74 · Net margin −1.7% · Return on equity −18.4% · Return on assets (EBIT) −13.6% (5-year average) · Operating margin −32.3% · Revenue (TTM) 15.6M SGD · Revenue growth (YoY) +27.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 9 out of 100 (low confidence).
What moves the price
The share trades about 72% below its 52-week high and 49% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −2% fair-value upside, at −50%, QZG screens richer than that median.
Fair Value models
All 6 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
QZG screens overvalued: fair value 50% below the price. Compare with HCA Healthcare, Inc →
Compare ACCRELIST LTD with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 249 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Information Technology sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- Piotroski F-Score screener with fair value
- Valuation of the Singapore market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $22.03 | $45.73 | +108% | vs QZG |
| DaVita Inc DVA | $174.56 | $218.90 | +25% | vs QZG |
| Aier Eye Hospital Group 300015 | ¥8.99 | ¥10.88 | +21% | vs QZG |
| HCA Healthcare, Inc HCA | $499.05 | $547.34 | +10% | vs QZG |
| Tenet Healthcare Corporation THC | $286.03 | $279.20 | −2% | vs QZG |
| The Ensign Group ENSG | $188.41 | $140.09 | −26% | vs QZG |
| Encompass Health Corporation EHC | $140.99 | $94.81 | −33% | vs QZG |
| Fresenius SE FRE | €53.86 | €34.77 | −35% | vs QZG |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,771 | ₹5,234 | −40% | vs QZG |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 211.40 SAR | 109.45 SAR | −48% | vs QZG |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is ACCRELIST LTD (QZG) overvalued or undervalued?
What is the fair value of QZG?
What is the quality score of QZG?
What is the price target for ACCRELIST LTD (QZG)?
What is the ACCRELIST LTD stock forecast for 2026?
What is the revenue of ACCRELIST LTD (QZG)?
What growth is priced into ACCRELIST LTD (QZG)?
What discount rate (WACC) does the fair value of QZG use?
What is a reverse DCF?
How much growth has ACCRELIST LTD (QZG) delivered so far?
How fast is the sector of ACCRELIST LTD (QZG) growing?
What is the free cash flow yield of ACCRELIST LTD (QZG)?
What is the intrinsic value of ACCRELIST LTD (QZG)?
Is ACCRELIST LTD stock overvalued or undervalued in 2026?
Is fair value the same as the market price of QZG?
How much is ACCRELIST LTD worth?
How solid is the balance sheet of ACCRELIST LTD (QZG)?
How far is QZG from its 52-week high?
Which stocks are comparable to ACCRELIST LTD?
Is ACCRELIST LTD stock attractive at the current price?
How is the fair value of QZG calculated?
Is it still worth investing in stocks now?
What is the share price of ACCRELIST LTD (QZG)?
What should I pay attention to with ACCRELIST LTD right now?
Key figures of ACCRELIST LTD
How large is the market capitalisation of ACCRELIST LTD (QZG)?
What is the P/S ratio of ACCRELIST LTD (QZG)?
What is the net margin of ACCRELIST LTD (QZG)?
What is the return on equity of ACCRELIST LTD (QZG)?
What is the EBIT return on assets of ACCRELIST LTD (QZG)?
What is the operating margin of ACCRELIST LTD (QZG)?
How fast is revenue growing at ACCRELIST LTD (QZG)?
How fast are earnings growing at ACCRELIST LTD (QZG)?
How much net debt does ACCRELIST LTD (QZG) carry?
Watch ACCRELIST LTD in the live analysis
One click puts ACCRELIST LTD on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.